Schürer Qiong, Shaban Hamdy, Gantenbein Andreas R, Todeschini Giada, Pradhan Saroj K
Research Department, Swiss TCM UNI, 5330 Bad Zurzach, Switzerland.
Department of Psychiatry Private Clinic of UPK, The University Psychiatric Clinics, 4002 Basel, Switzerland.
Medicines (Basel). 2022 Aug 12;9(8):44. doi: 10.3390/medicines9080044.
: Multiple sclerosis (MS) is an autoimmune, chronic, inflammatory, demyelinating, and axonal degeneration disease of the central nervous system. Trigeminal neuralgia (TN), a neuropathic facial paroxysmal pain, is prevalent among MS patients. Because of the inadequacy of the comprehension of MS-related TN pathophysiological mechanisms, TN remains arduous in its treatment approaches. Acupuncture as a non-pharmacological therapy could be a promising complementary therapy for the treatment of TN. MS gradual neural damage might affect the muscles' function. This can lead to acute or paroxysmal pain in the form of spasms that might progress to formation of myofascial trigger points also known in traditional Chinese medicine as Ashi points (AP). Localising these AP through palpation and pain sensation feedback in patients with MS is an indicator of disease progression. Pathologically, these points reveal the disharmony of soft tissue and internal organs. Methods: This case report examined the pain relief outcome with Ashi scalp acupuncture (ASA) in a secondary TN patient who was unsuccessfully treated multiple times with body acupuncture. The main outline measure was to quantify pain intensity using a numerical rating scale (NRS) before and after each acupuncture therapy. The patient was treated on the scalp for a total of eight times, twice a week over four weeks. : A reduction in secondary TN pain intensity was observed after each session. On average, the patient expressed severe pain (NRS: 8.0 ± 2.20) before ASA treatment, which significantly decreased after therapy to mild pain (NRS: 2.0 ± 1.64). : Significant improvements in pain intensity reduction after each acupuncture treatment without any adverse effects were observed.
多发性硬化症（MS）是一种中枢神经系统的自身免疫性、慢性、炎症性、脱髓鞘和轴索性变性疾病。三叉神经痛（TN）是一种神经性面部阵发性疼痛，在MS患者中很常见。由于对与MS相关的TN病理生理机制理解不足，TN的治疗方法仍然很艰巨。针灸作为一种非药物疗法，可能是治疗TN的一种有前景的辅助疗法。MS逐渐的神经损伤可能会影响肌肉功能。这可能导致以痉挛形式出现的急性或阵发性疼痛，这种疼痛可能会发展为肌筋膜触发点的形成，在中医中也称为阿是穴（AP）。通过触诊和MS患者的疼痛感觉反馈来定位这些阿是穴是疾病进展的一个指标。从病理上来说，这些穴位揭示了软组织和内脏的不协调。方法：本病例报告研究了阿是头皮针（ASA）对一名继发性TN患者的止痛效果，该患者多次接受体针治疗均未成功。主要的概述测量方法是在每次针灸治疗前后使用数字评分量表（NRS）来量化疼痛强度。该患者在头皮上共接受了八次治疗，每周两次，持续四周。：每次治疗后均观察到继发性TN疼痛强度降低。平均而言，患者在ASA治疗前表示有重度疼痛（NRS：8.0±2.20），治疗后显著降低至轻度疼痛（NRS：2.0±1.64）。：观察到每次针灸治疗后疼痛强度显著降低，且无任何不良反应。
